Table 3. Toxicities.

Variable	Cap (N=36), n [%]	5-FU (N=32), n [%]	Total (N=68), n [%]	P value
Hematological toxicities (≥ grade 3)
Neutropenia	5 [14]	6 [19]	11 [16]	0.744
Anemia	3 [8]	2 [6]	5 [7]	0.557
Thrombocytopenia	0 [0]	1 [3]	1 [1]	0.471
Common non-hematological toxicities
Radiation dermatitis				0.740
Grade 2	13 [36]	11 [34]	24 [35]
Grade 3	14 [39]	15 [47]	29 [43]
Anal pain				0.159
Grade 2	28 [78]	18 [56]	46 [68]
Grade 3	3 [8]	4 [13]	7 [10]
Diarrhea				0.556
Grade 2	12 [33]	15 [47]	27 [40]
Grade 3	6 [17]	5 [16]	11 [16]
Nausea				0.236
Grade 2	9 [25]	3 [9]	12 [18]
Grade 3	2 [6]	2 [6]	4 [6]
Uncommon non-hematological toxicities (≥ grade 2)
Stomatitis	2 [6]	10 [31]	12 [18]	0.009
Skin/soft tissue infection	3 [8]	2 [6]	5 [7]	1.000
Cystitis	8 [22]	4 [13]	12 [18]	0.353
Proctitis	4 [11]	2 [6]	6 [9]	0.676
Deep vein thrombosis	0 [0]	4 [13]	4 [6]	0.044
Acute coronary syndrome	2 [6]	2 [6]	4 [6]	1.000
Hand and foot syndrome	4 [11]	5 [16]	9 [13]	0.725

Cap, capecitabine; 5-FU, 5 fluorouracil.